Tirzepatide under $300 a month, graded

What counts as under $300 on this page

A provider is listed here when its lowest standing monthly price for compounded tirzepatide is below $300. Standing means the rate you keep paying month to month: not a first-month offer, not a rate that needs a prepaid plan, and not a coupon.

11 providers with a published check clear that line. Their figures run from $149 to $270.49, with a median of $214. Every row qualifies on an injection.

4 of the 11 pass all 4 checks. The lowest figure is $149 on a B row; the lowest on an A row is SnagRx at $149. How we check explains the grades.

What a year costs at each end of the list

Twelve months at the lowest standing figure is $1,788; at the highest it is $3,245.88, and at the median $2,568. The annualized comparison gap is $1,457.88. Actual first-year cash payments depend on the charge dates; the preparations and included services may also differ.

That spread is why the grade and the price both matter here. Every row is under the line, so the line alone can't choose for you; the 4 check chips and the fine print can.

A card's figure covers the medication as the provider prices it. Ask whether labs, shipping or a visit fee are billed separately.

The opening offer isn't the price you budget for

2 providers here print a lower first payment than their standing rate. The card shows the standing monthly comparison figure. Confirm the actual recurring charge and interval in the selected agreement.

Some offers also need a code or a first-order coupon. Those never count toward this page's line, and neither does a lower rate that applies only to a bundle of months.

An offer is worth taking only if the standing rate is one you'd pay anyway. Read the second number first.

A 4-week plan bills at 28-day intervals

1 provider bills every 4 weeks or 28 days. Luvo Health charges $249 each time, which annualizes to $3,245.89 over 365 days. A day-zero start can mean fourteen cash payments in the first 365 days. The card shows $270.49, the calendar-month figure.

Some prices rise with the dose, some don't

A prescriber may raise the dose over time, so ask what each step costs. 2 providers here say in their own price text that one price covers every dose: PlexusDx and Precision Telemed.

At least 1 prints a price for a specific dose or says the price depends on it: Arc-1. For those, the card figure is the price at the starting dose, and later months can cost more.

A flat price is easier to budget, but it isn't automatically lower. Set a flat figure against what a dose-priced provider would charge at the dose you expect to reach, not only at the start.

The rest don't say either way. That isn't a flat price; it's a question to put in writing before you join.

Prepaid plans lower the monthly figure, not the commitment

At least 6 of the 11 also sell a 3-, 6- or 12-month plan at a lower monthly rate. This page ignores those rates on purpose. A prepaid plan charges several months up front, and if you stop early, the refund terms decide what you get back.

If the standing rate is already under $300, a prepay buys a discount, not access. Ask for the cancellation terms before you choose the longer plan.

Against the brand, and where compounded tirzepatide stands

Tirzepatide is FDA-approved as Zepbound and Mounjaro; the compounded versions on this page are not. FDA doesn't check a compounded product's quality or dose accuracy before it ships, and it reported more than 730 adverse-event submissions through May 31, 2026. Those reports do not establish causation or an incidence rate.

The brand label carries a boxed warning about thyroid C-cell tumors seen in rodents. It belongs to the molecule, not the brand, so raise it with your prescriber whichever version you buy.

FDA declared the tirzepatide shortage over at the end of 2024, and the shortage-era compounding windows closed in early 2025. A 2026 update says tirzepatide is on neither the shortage list nor the bulks list for outsourcing facilities. Ask the provider which pharmacy compounds yours and on what basis. A low price cannot establish that a compounded product meets the legal conditions or that its formulation is equivalent to a brand product.

2 providers here also offer brand tirzepatide. Luvo Health lists it at $1,519.75 a month. Another charges a program fee and leave the drug's price to the maker. Obtain the manufacturer’s current quote for the selected dose and eligibility. A limited starting offer is not a verified ongoing medication price.